Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Jan;32(1):93-100.
doi: 10.1055/s-0034-1374815. Epub 2014 May 16.

Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

Brian M Casey  1 , Lisa Mele  2 , Mark B Landon  3 , Catherine Y Spong, Susan M Ramin  4 , Ronald J Wapner  5 , Michael W Varner  6 , Dwight J Rouse  7 , John M Thorp Jr  8 , Patrick Catalano  9 , Margaret Harper  10 , George Saade  11 , Yoram Sorokin  12 , Alan M Peaceman  13 ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
Affiliations
Randomized Controlled Trial

Does maternal body mass index influence treatment effect in women with mild gestational diabetes?

Brian M Casey et al. Am J Perinatol. 2015 Jan.

Abstract

Objective: The aim of the article is to determine whether maternal body mass index (BMI) influences the beneficial effects of diabetes treatment in women with gestational diabetes mellitus (GDM).

Study design: Secondary analysis of a multicenter randomized treatment trial of women with GDM. Outcomes of interest were elevated umbilical cord c-peptide levels (> 90th percentile 1.77 ng/mL), large for gestational age (LGA) birth weight (> 90th percentile), and neonatal fat mass (g). Women were grouped into five BMI categories adapted from the World Health Organization International Classification of normal, overweight, and obese adults. Outcomes were analyzed according to treatment group assignment.

Results: A total of 958 women were enrolled (485 treated and 473 controls). Maternal BMI at enrollment was not related to umbilical cord c-peptide levels. However, treatment of women in the overweight, Class I, and Class II obese categories was associated with a reduction in both LGA birth weight and neonatal fat mass. Neither measure of excess fetal growth was reduced with treatment in normal weight (BMI < 25 kg/m(2)) or Class III (BMI ≥ 40 kg/m(2)) obese women.

Conclusion: There was a beneficial effect of treatment on fetal growth in women with mild GDM who were overweight or Class I and Class II obese. These effects were not apparent for normal weight and very obese women.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Figure 1
Figure 1
Percent LGA according to maternal body mass index (BMI) and treatment group in women with mild gestational diabetes who were randomized to either diet therapy and glucose monitoring or routine prenatal care. The X2 or Fisher exact test was used to compare treatment groups within BMI category.
Figure 2
Figure 2
Neonatal Fat Mass (grams) according to maternal body mass index (BMI) and treatment group in women with mild gestational diabetes that were randomized to either diet therapy and glucose monitoring or routine prenatal care. The Wilcoxon rank sum test was used to compare treatment groups within BMI category.
See this image and copyright information in PMC

References

    1. Schaefer-Graf UM, Heuer R, Kilavuz O, Pandura A, Henrich W, Vetter K. Maternal obesity not maternal glucose values correlates best with high rates of fetal macrosomia in pregnancies complicated by gestational diabetes. J Perinat Med. 2002;30:313–21. - PubMed
    1. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191:964–8. - PubMed
    1. Schaffer-Graf UM, Kjos SL, Kilavuz O, et al. Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance. Diabetes Care. 2003;26:193198. - PubMed
    1. Voldner N, Qvigstad E, Froslie KF, et al. Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Maternal Fetal and Neonate Med. 2010;23(1):74–81. - PubMed
    1. HAPO Cooperative Research Group. Hyperglycaemia and adverse pregnancy outcome (HAPO) study. BJOG. 2010;175:575–84. - PubMed

Publication types

Grants and funding